Regulated Information - Global

Regulated Information

Filter

Period

Filter by

recent search

Showing: 105 of 152 Regulated Information

New patient-reported data demonstrated high satisfaction levels and fewer patients reporting injection-site pain with Somatuline® Autogel®/Somatuline® Depot (lanreotide)
New patient-reported data demonstrated high satisfaction levels and fewer patients reporting injection-site pain with Somatuline® Autogel®/Somatuline® Depot (lanreotide)

PARIS, France, 8 March 2022 – Ipsen (Euronext: IPN; ADR: IPSEY) published today new data from seven abstracts to be presented at the hybrid-setting 19th Annual European Neuroendocrine Tumor Society (ENETS) Conference, 10-11 March 2022, in Barcelona, Spain. Presentations include data from…



Ipsen : 2023 CSM - Formalities for making available preparatory documents to the Meeting
Ipsen : 2023 CSM – Formalities for making available preparatory documents to the Meeting

INFORMATION RELATING TO THE HOLDING OF THE COMBINED SHAREHOLDERS’ MEETING OF 31 MAY 2023



Combined Shareholders’ Meeting of 31 May 2023
Combined Shareholders’ Meeting of 31 May 2023

Please download the associated documents for more information.


1 15 16 17 18 19 20 21 31